BRAINSTORM CELL THERAPEUTICS INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Brainstorm Cell Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Brainstorm Cell Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 5.31M shares, a 88.3% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.31M -40M -88.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 79.6M +38.7M +94.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 68.4M +30M +77.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 4.03M -32.7M -89% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 45.3M +8.77M +24% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 40.9M +4.44M +12.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 38.5M +1.99M +5.45% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 36.7M +293K +0.8% Dec 31, 2022 10-K 2024-04-01
Q3 2022 36.5M +264K +0.73% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 36.5M +168K +0.46% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 36.5M +168K +0.46% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 36.4M +1.24M +3.53% Dec 31, 2021 10-K 2023-03-30
Q3 2021 36.3M +4.71M +14.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 36.3M +6.65M +22.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 36.3M +7.89M +27.8% Mar 31, 2021 10-Q 2021-04-26
Q4 2020 35.2M +12M +51.7% Dec 31, 2020 10-K 2022-03-28
Q3 2020 31.6M +8.96M +39.6% Sep 30, 2020 10-Q 2020-10-15
Q2 2020 29.7M +7.96M +36.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 28.4M +6.93M +32.3% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 23.2M +2.42M +11.6% Dec 31, 2019 10-K 2021-02-04
Q3 2019 22.6M +1.91M +9.21% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 21.7M +1.04M +5.03% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 21.5M +2.38M +12.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 20.8M +1.78M +9.39% Dec 31, 2018 10-K 2020-02-18
Q3 2018 20.7M +1.86M +9.86% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 20.7M +1.92M +10.3% Jun 30, 2018 10-Q 2018-07-23
Q1 2018 19.1M +412K +2.2% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 19M +288K +1.54% Dec 31, 2017 10-K/A 2019-04-01
Q3 2017 18.8M +155K +0.83% Sep 30, 2017 10-Q 2017-10-17
Q2 2017 18.7M +93.3K +0.5% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 18.7M +45.6K +0.25% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 18.7M +44.7K +0.24% Dec 31, 2016 10-K 2018-03-08
Q3 2016 18.7M +207K +1.12% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 18.7M +173K +0.94% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 18.7M +260K +1.42% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 18.6M +3.36M +22% Dec 31, 2015 10-K 2017-03-29
Q3 2015 18.5M +3.25M +21.4% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 18.5M -207M -91.8% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 18.4M -158M -89.6% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 15.3M +3.53M +30% Dec 31, 2014 10-K 2016-03-09
Q3 2014 15.2M -161M -91.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 225M +72.8M +47.6% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 177M +24.9M +16.4% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 11.8M -138M -92.2% Dec 31, 2013 10-K 2015-03-26
Q3 2013 176M +26.2M +17.4% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 153M +24.1M +18.8% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 152M +25.1M +19.8% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 150M +23.6M +18.7% Dec 31, 2012 10-K 2014-03-27
Q3 2012 150M +24.5M +19.5% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 129M +6.01M +4.91% Jun 30, 2012 10-Q/A 2012-08-29
Q1 2012 127M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 126M +30.6M +31.9% Dec 31, 2011 10-K 2013-03-14
Q3 2011 126M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 123M Jun 30, 2011 10-Q/A 2011-09-07
Q4 2010 95.8M Dec 31, 2010 10-K 2012-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.